Journal of The Cardiometabolic Syndrome
Papers 194
1 page of 20 pages (194 results)
#1Ahmet Selçuk CanH-Index: 4
Last. Thomas P. Bersot (UCSF: University of California, San Francisco)H-Index: 29
view all 4 authors...
The Turkish Cardiovascular Risk Platform (TCRP) calls for the diagnosis of the metabolic syndrome (MS) if insulin resistance, impaired fasting glucose, impaired glucose tolerance, or diabetes mellitus and ≥2 other established criteria are present. TCRP defines insulin resistance as a homeostasis model assessment >2.7. The aim of this cross-sectional study was to compare TCRP guidelines with the United States National Cholesterol Education Program Adult Treatment Panel III (NCEP) definition of MS...
#1Sowmya Krishnan (University of Oklahoma Health Sciences Center)H-Index: 10
#2Kevin R. Short (University of Oklahoma Health Sciences Center)H-Index: 36
Type 1 diabetes (T1D) is a common disease of childhood with a current prevalence of almost 2 cases per 1000 adolescents according to the third National Health and Nutrition Examination Survey (NHANES). Modern insulin treatment has resulted in improved quality of life for children diagnosed with this chronic disorder. However, T1D continues to carry a long term burden of increased microvascular and macrovascular complications and mortality risk. Compared to the non-diabetic population patients wi...
28 CitationsSource
#1Jordan Kawano (RFUMS: Rosalind Franklin University of Medicine and Science)H-Index: 1
#2Rohit Arora (RFUMS: Rosalind Franklin University of Medicine and Science)H-Index: 24
Nearly 1 in 4 adults in the United States is obese. The connection between obesity and insulin resistance, type 2 diabetes, and cardiovascular disease is a well researched one. The increasing prevalence of each of these diseases has become a growing concern for the medical community. Adiponectin is a collagen-like plasma protein secreted by adipocytes that has been suggested to play a causal role in the development of insulin resistance and cardiovascular disease. The protein has been found to b...
115 CitationsSource
#1Sari Halpert (SUNY Downstate Medical Center)H-Index: 1
#2Samy I. McFarlane (SUNY Downstate Medical Center)H-Index: 31
4 CitationsSource
#1Michael S. Kostapanos (UoI: University of Ioannina)H-Index: 22
#2Evangelos N. Liberopoulos (UoI: University of Ioannina)H-Index: 38
Last. Moses Elisaf (UoI: University of Ioannina)H-Index: 63
view all 3 authors...
Statins may exhibit significant renoprotective effects beyond their lipid-lowering capacity. Herein, the authors review data from human and animal models of renal disease as well as from studies in cultured renal cells with regard to extralipid renoprotective properties of statins. Statins may exert lipid-independent benefits against renal injury in experimental states of chronic or acute renal function impairment. These include diabetic and hypertensive glomerulosclerosis, autoimmune glomerulon...
26 CitationsSource
#1Martin A. Alpert (MU: University of Missouri)H-Index: 37
#2Gurushankar Govindarajan (MU: University of Missouri)H-Index: 10
Last. Efrain Reisin (MU: University of Missouri)H-Index: 1
view all 4 authors...
Chronic kidney disease and cardiovascular disease share many risk factors, including hypertension, obesity, and insulin resistance. All of these are components of the cardiometabolic syndrome and are associated with increased risk of morbidity and mortality. One mechanism that links renal injury with the cardiometabolic syndrome is activation of the renin-angiotensin system. Chronic angiotensin II activation promotes development of renal disease through hemodynamic effects and up-regulation of i...
7 CitationsSource
#1Maurizio Bevilacqua (University of Milan)H-Index: 23
#2Ligia J. Dominguez (University of Palermo)H-Index: 31
Last. Mario Barbagallo (University of Palermo)H-Index: 38
view all 3 authors...
Highly active antiretroviral therapy (HAART) has dramatically improved the prognosis of HIV-positive patients. However, long-term adverse effects of this therapy include dyslipidemia, insulin resistance (IR), changes in body fat distribution (lipodystrophy), and cardiometabolic syndrome (CMS). IR in HIV-positive patients does not seem to represent a significant independent risk factor for the development of cardiovascular disease; nevertheless, the association with other metabolic complications ...
15 CitationsSource
#1Allison H. Christian (Columbia University)H-Index: 4
#2Heidi Mochari (Columbia University)H-Index: 8
Last. Lori Mosca (Columbia University)H-Index: 49
view all 3 authors...
Total body fat and adipose tissue distribution are associated with cardiometabolic risk, yet there are conflicting data as to whether waist circumference (WC) or body mass index (BMI) is a better predictor of cardiovascular risk. To determine whether WC or BMI was more strongly associated with cardiometabolic risk, family members of patients with cardiac disease were studied (N=501; mean age, 48 years; 66% female; 36% nonwhite). Height, weight, WC, BMI, blood pressure, high-density lipoprotein c...
34 CitationsSource
#1Icilma Fergus (CUMC: Columbia University Medical Center)H-Index: 8
7 CitationsSource
#1Venkata Narla (Johns Hopkins University)H-Index: 4
#2Raul D. Santos (USP: University of São Paulo)H-Index: 41
Last. Erin Donnelly Michos (Johns Hopkins University)H-Index: 41
view all 8 authors...
A number of metabolic syndrome (MS) definitions exist, and one’s cardiovascular disease risk may depend on the definition used. The authors compared the association of subclinical atherosclerosis (coronary artery calcification [CAC] score >0] and inflammation (white blood cell [WBC] count greater than or equal to the highest quartile) with 3 definitions of MS (those of the National Cholesterol Education Program Adult Treatment Panel III [NCEP ATP III], the American Heart Association/National Hea...
4 CitationsSource
Top fields of study
Insulin resistance
Metabolic syndrome
Diabetes mellitus